Skip to Content
  • Previous Rank23
  • Revenues ($M)$153,144
  • Revenue Percent Change4.3%
  • Profits ($M)$364.5
  • Profits Percent Change-74.5%
  • Assets ($M)$35,316.50
  • Employees19,500

The Pennsylvania-based drug distributor saw revenues grow in 2017 thanks to increased business from some of its largest customers and strong sales of expensive cancer drugs. Amerisources’s animal health unit, MWI, also recorded strong sales growth thanks to its brisk pet medicine business. Profits took a hit due to accrued litigation costs from the previous year. Like other large drug distributors, Amerisource faces a number of lawsuits over its alleged role in the nation’s opioid epidemic.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Information

Steven H. Collis
Wholesalers: Health Care
HQ Location
Chesterbrook, Pa.
Years on Global 500 List19
Figures are for fiscal year ended Sept. 30, 2017.

AmerisourceBergen Rank History

Key Financials (Last Fiscal Year)

($ Millions)% change
Revenues ($M)$153,1444.3%
Profits ($M)$364.5-74.5%
Assets ($M)$35,316.50-
Total Stockholder Equity ($M)$2,064.50-

Profit Ratios

Profit as % of Revenues0.2%
Profits as % of Assets1%
Profits as % of Stockholder Equity17.7%